Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants

NCT06753955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody
Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
Autoimmune Encephalitis

Interventions

DRUG: ART5803
DRUG: Intravenous immunoglobulin (IVIG)

Sponsor

Arialys Therapeutics